Skip to main content
. 2023 Nov 10;19(2):244–247. doi: 10.2174/1574886318666230726124540

Table 2.

A summary of all adverse events reported in the literature among patients treated with proton pump inhibitors.

Death
Hospitalization
Cardiovascular events
Cerebral ischemic diseases
Ischemic cardiac diseases
Acute kidney injury
Chronic kidney disease
Dementia
Cancers
Digestive tract cancers
Gastric cancer
Colon cancer
Colorectal cancer
Hepatocellular carcinoma
Esophageal Adenocarcinoma
Barrett’s Esophagus
Pancreatic cancer
Bone Fractures / Falls
Changes in gut microbiome
Gastric fundic gland polyps
Small intestinal bacterial overgrowth
Gastrointestinal infection
Fundic gland polyps
Gut dysbiosis
Microscopic colitis
Clostridium difficile
Vitamin B12 deficiency
Iron deficiency
Anemia
Hypomagnesemia
Drug interaction
Laboratory findings
Glycemic Control
Gastrin Levels and Gastric Histology
Dental implant failure
Myopathy
Hepatic encephalopathy
Pneumonia
Childhood asthma
Following use in pregnancy
Community-acquired pneumonia
COPD
Tuberculosis
COVID-19